about
Cushing's disease in 2012.Reduction of trabecular and cortical volumetric bone mineral density at the proximal femur in patients with acromegaly.Hypoglycemia associated with fluoxetine treatment in a patient with type 1 diabetes.[Langerhans cell histiocytosis associated with papillary thyroid carcinoma].[Abnormalities of carbohydrate metabolism in acromegaly].Cystatin-C and epicardial adipose tissue as noninvasive predictors of cardiovascular risk in acromegaly.Epicardial fat is a negative predictor of spine volumetric bone mineral density and trabecular bone score in acromegaly.[Gestational diabetes mellitus and maternal ethnicity: high prevalence of fetal macrosomia in non-Caucasian women].Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study[Cushing syndrome with clinical response to beta-blockers][Interns' viewpoints and knowledge about management of hyperglycemia in the hospital setting]Communication between primary care and physician specialist: is it improving?[Prevalence of benign and malignant tumors in acromegalic patients][Glucose renal excretion as diabetes treatment: From an old diagnostic method to a new way of treatment][Reply to letter to the editor: «Terminology and communication between healthcare levels»]Ectopic Cushing's syndrome: Paradoxical effect of somatostatin analogsMetabolic Fingerprint of Acromegaly and its Potential Usefulness in Clinical PracticeAcromegaly remission, SIADH and pituitary function recovery after macroadenoma apoplexy
P50
Q38138243-60E32896-9825-4380-A99E-DAB4A554B39BQ40360442-88BEA3CC-3AB0-41FB-AB54-35DD08B1A109Q42856885-AFA12C56-15D5-43A4-AF5E-CCCC12BB2BFEQ43445617-12BE4D45-F0EA-45B5-AE7E-6A5CD10A73B5Q45290828-A0E5B761-74EC-452E-A140-8EAEFD9619D8Q50222299-07FD952F-54E2-4D18-B68C-5C92C7017099Q50245386-E6177ED9-849C-47D0-A2F9-C82D5EAB1C36Q51353397-6C3A1D14-2CAA-427C-AF96-D80091C84237Q62559156-B58032FF-4352-4043-BDE4-B9B3EFE9D3A9Q83608122-45E50707-E39D-4B9B-A4D8-820EB7D4932EQ84573263-60057BF4-4953-4E30-9086-A3DF86682048Q85260447-CF70AEB0-8197-4973-A4C1-CB4A0C1F02DFQ86845807-C6DF2F9E-AAA8-4DF4-9AE2-3F4F1E8CF864Q87180336-B8832C87-F2FF-4746-B465-1852916941A7Q88006434-7F7EB3A2-5352-43B9-83F4-8067CD3053FBQ89700028-F3ECB02E-0D45-4331-9504-220904D5CB89Q90335291-B58E9A00-403A-48CE-82A4-2B0BF3E0789CQ91918693-0B202AA6-BF2B-4B25-9C35-68CD06647AFC
P50
description
researcher ORCID ID = 0000-0002-8837-4343
@en
wetenschapper
@nl
name
Betina Biagetti
@ast
Betina Biagetti
@en
Betina Biagetti
@es
Betina Biagetti
@nl
type
label
Betina Biagetti
@ast
Betina Biagetti
@en
Betina Biagetti
@es
Betina Biagetti
@nl
prefLabel
Betina Biagetti
@ast
Betina Biagetti
@en
Betina Biagetti
@es
Betina Biagetti
@nl
P1153
24437435800
P31
P496
0000-0002-8837-4343